Cost-sharing of 0%, 35%, 70%, 85%, depending on drug category, plus co-payment of EUR 0.5 per item. Any difference between retail price and Òreference priceÓ for products subject to reference pricing (about 5% of drugs dispensed) is paid by the patient.